Literature DB >> 27325478

Decline of Tumor Vascular Function as Assessed by Dynamic Contrast-Enhanced Magnetic Resonance Imaging Is Associated With Poor Responses to Radiation Therapy and Chemotherapy.

Fang-Hsin Chen1, Chun-Chieh Wang1, Ho-Ling Liu2, Sheng-Yung Fu3, Ching-Fang Yu4, Chen Chang5, Chi-Shiun Chiang3, Ji-Hong Hong6.   

Abstract

PURPOSE: To investigate whether changes in the volume transfer coefficient (K(trans)) in a growing tumor could be used as a surrogate marker for predicting tumor responses to radiation therapy (RT) and chemotherapy (CT). METHODS AND MATERIALS: Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) was consecutively performed on tumor-bearing mice, and temporal and spatial changes of K(trans) values were measured along with tumor growth. Tumor responses to RT and CT were studied before and after observed changes in K(trans) values with time.
RESULTS: Dynamic changes with an initial increase and subsequent decline in K(trans) values were found to be associated with tumor growth. When each tumor was divided into core and peripheral regions, the K(trans) decline was greater in core, although neither vascular structure or necrosis could be linked to this spatial difference. Tumor responses to RT were worse if applied after the decline of K(trans), and there was less drug distribution and cell death in the tumor core after CT.
CONCLUSION: The K(trans) value in growing tumors, reflecting the changes of tumor microenvironment and vascular function, is strongly associated with tumor responses to RT and CT and could be a potential surrogate marker for predicting the tumor response to these treatments.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27325478     DOI: 10.1016/j.ijrobp.2016.03.051

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  5 in total

1.  Diffusion-weighted MRI and 18F-FDG PET correlation with immunity in early radiotherapy response in BNL hepatocellular carcinoma mouse model: timeline validation.

Authors:  Yi-Hsiu Chung; Ching-Fang Yu; Shao-Chieh Chiu; Han Chiu; Shin-Ting Hsu; Ching-Rong Wu; Chung-Lin Yang; Ji-Hong Hong; Tzu-Chen Yen; Fang-Hsin Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-05-24       Impact factor: 9.236

2.  The impact of injector-based contrast agent administration in time-resolved MRA.

Authors:  Johannes Budjan; Ulrike I Attenberger; Stefan O Schoenberg; Hubertus Pietsch; Gregor Jost
Journal:  Eur Radiol       Date:  2017-12-07       Impact factor: 5.315

3.  Dynamics of angiogenesis and cellularity in rabbit VX2 tumors using contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging.

Authors:  Haixia Li; Lijuan Yu; Wenzhi Wang; Lingling Wang; Xiulan Zheng; Shaochun Dai; Yanqin Sun
Journal:  Oncol Lett       Date:  2017-12-19       Impact factor: 2.967

4.  Ultra-early changes in vascular parameters from dynamic contrast enhanced MRI of breast cancer xenografts following systemic therapy with doxorubicin and liver X receptor agonist.

Authors:  Kathinka E Pitman; Kine M Bakke; Alexandr Kristian; Eirik Malinen
Journal:  Cancer Imaging       Date:  2019-12-19       Impact factor: 3.909

5.  Ablative Radiotherapy Reprograms the Tumor Microenvironment of a Pancreatic Tumor in Favoring the Immune Checkpoint Blockade Therapy.

Authors:  Yu-Hung Lee; Ching-Fang Yu; Ying-Chieh Yang; Ji-Hong Hong; Chi-Shiun Chiang
Journal:  Int J Mol Sci       Date:  2021-02-19       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.